Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful pharmacological management of a child with compound heterozygous familial hypercholesterolemia and review of the recent literature.

Journal of clinical lipidology - 1 Jan 2000

Sreedharan Aravind Venkatesh, Pek Sharon Li Ting, Tan Teng Hong, Tavintharan Subramaniam, Yap Fabian

Abstract excerpt

Severe familial hypercholesterolemia (SFH) is characterized by markedly elevated low-density lipoprotein cholesterol (LDL-C) and severe early-onset cardiovascular disease if left untreated. We report on the decade-long therapeutic journey of a 15-year-old boy with SFH due to a severe compound heterozygous genotype. He presented at the age of 5 years with widespread xanthomas and LDL-C of 17.4 mmol/L. He was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Anticholesteremic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, LDL

Share to Genetic Predisposition to Disease

Share to Heterozygote

Share to Hyperlipoproteinemia Type II

Share to Prognosis

Share to Receptors, LDL

Source

Identifiers

PMID: 32800790
DOI: 10.1016/j.jacl.2020.07.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Successful pharmacological management of a child with compound heterozygous familial hypercholesterolemia and review of the recent literature.PMID 32800790Read ↗

Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors.Semantic proximity Read ↗

Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives.Semantic proximity Read ↗

Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.Semantic proximity Read ↗

Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.Semantic proximity Read ↗

Evidence for improved survival with treatment of homozygous familial hypercholesterolemiaSemantic proximity Read ↗

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Semantic proximity Read ↗

Lipid Screening, Action, and Follow-up in Children and Adolescents.Semantic proximity Read ↗

Autosomal recessive hypercholesterolemia in a kindred of Syrian ancestry.Semantic proximity Read ↗

Targeted NGS Revealed Pathogenic Mutation in a 13-Year-Old Patient with Homozygous Familial Hypercholesterolemia: A Case Report.Semantic proximity Read ↗

Long-Term Follow-up of a Homozygous Familial Hypercholesterolemia Child with Progressive Aortic Stenosis and Coronary AtherosclerosisSemantic proximity Read ↗

[Three-year-old boy--a homozygote for familiar hypercholesterolemia].Semantic proximity Read ↗

From physiopathology to treatment of familial hypercholesterolemia: Existing and emerging pharmacotherapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.